AHA Scientific Sessions, ISCHEMIA Descend on Philadelphia

Share this post

The 3-day meeting has a mix of cardiovascular science, but all eyes will be on the controversial ISCHEMIA trial and whether an invasive approach to ischemia offers patients more than medical therapy.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply